ANTI- A1 LECTIN.
Mexico·Clase II·III. DIAGNOSTIC AGENTS·KABLA COMERCIAL, S.A. DEC.V.·Registered August 04, 2020PARADETERMINARELSUBGRUPODESANGREA1. AGENTES DE DIAGNÓSTICO PARA USO INVITRO, PARA USO EXCLUSIVO ENLABORATORIOS CLÍNICOS Ó DE GABINETE.
TO DETERMINE the blood subgroupA1. DIAGNOSTIC AGENTS FOR INVITRO USE, FOR EXCLUSIVE USE IN CLINICAL LABORATORIES OR CABINET.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ANTISUERO PARA TIPIFICAR SANGRE.
- Trade Name (English)
- ANTISERUM TO TYPE BLOOD.
- Analysis ID
- 1038R2020 SSA
- Registration Date
- August 04, 2020
- Name (Spanish)
- KABLA COMERCIAL, S.A. DEC.V.
- Name (English)
- KABBALAH COMMERCIAL, S.A. DEC.V.
Access comprehensive regulatory information for ANTI- A1 LECTIN. (ANTI- A1 LECTIN.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1038R2020 SSA and manufactured by KABLA COMERCIAL, S.A. DEC.V.. The device was registered on August 04, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.